18FluoroLDOPA PET Imaging for the Detection and Localization of Focal Congenital Hyperinsulinism

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 3, 2016

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Congenital Hyperinsulinism

Interventions

DRUG

18F-Fluoro Dopa Imaging

Imaging with 18F-Fluoro Dopa PET Imaging

Trial Locations (1)

RECRUITING

University of California, San Francisco, San Francisco

All Listed Sponsors

lead

Miguel Pampaloni

OTHER